ENDEAVOUR VISION SA
ENDEAVOUR VISION SA is a Seed, Series C+, expansion, development-capital, startup, early-stage and spinout fund in the US and Europe writing $3M–$30M checks into Healthcare, medical-devices, diagnostics, healthcare-tech and life-sciences.
- Stages
- Seed, Series C+, expansion, development-capital, startup, early-stage, spinout
- Sectors
- Healthcare, medical-devices, diagnostics, healthcare-tech, life-sciences
- Check size
- $3M–$30M
- Invests in
- US-wide, Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2000
- Assets under management
- €250 million
- Website
- endeavourvision.com
Thesis
Endeavour Vision SA is a venture capital and private equity firm founded in 2000, specializing in transformative healthcare technologies, particularly medical devices and digital health. Their investment thesis focuses on growth-stage companies with world-class technology addressing significant unmet needs in healthcare, aiming to improve patient outcomes and healthcare system efficiencies. They primarily invest in Europe and the United States, focusing on equity financing. The firm actively seeks to be a lead investor, often taking board seats to provide strategic guidance. Endeavour Vision has raised substantial capital, including the €250 million Endeavour Medtech Growth (EMG) LP fund in 2016 and EMG II LP with USD 375 million in 2021. Their typical investment ranges from USD 10-30 million over the lifetime of an investment, with other sources indicating a minimum of €10 million or above €3 million. The firm is committed to ESG principles, aiming for both positive social and financial returns.
Common questions
Does ENDEAVOUR VISION SA invest at the Seed stage?
Yes. ENDEAVOUR VISION SA lists Seed, Series C+, expansion, development-capital, startup, early-stage and spinout among the stages it invests in.
What check size does ENDEAVOUR VISION SA write?
ENDEAVOUR VISION SA writes $3M–$30M checks.
Where does ENDEAVOUR VISION SA invest?
ENDEAVOUR VISION SA invests in the US and Europe.